Skip to Content Skip to Search

About us

A new era for human health

About us

GSK is a global biopharma leader with ambition and purpose to unite science, technology and talent to get ahead of disease together.

Our purpose

Getting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the health of over 2.5 billion people in the next 10 years. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive.


Immune system T-cells attacking cancer cells


Herpes zoster virus of Shingles

How we do it

Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.


Innovation is at the heart of delivering GSK’s purpose, by using our science to develop better medicines and vaccines.

We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.


  • £4.3bn

    adjusted R&D investment in 2019

  • 40

    new medicines in development at Q3 2020

  • 18

    new vaccines in development at Q3 2020


We deliver growth by investing effectively in our business, developing our people and executing competitively.


  • £33.8bn

    turnover in 2019

  • £9bn

    adjusted operating profit in 2019

  • £5.1bn

    free cash flow in 2019

  • £4bn

    dividends paid in 2019


We are a responsible company – using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.


  • 78%

    employee engagement score on our latest employee survey

  • £263m

    donated in 2019 to community health programs

  • 1st

    in Access to Medicines Index since the assessment began in 2008